Home Cart Sign in  
Chemical Structure| 3605-01-4 Chemical Structure| 3605-01-4

Structure of Piribedil
CAS No.: 3605-01-4

Chemical Structure| 3605-01-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Piribedil is an antiparkinsonian agent and piperazine derivative which acts as a D2 and D3 receptor agonist.

Synonyms: Trivastal; Trivastan; EU 4200

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Piribedil

CAS No. :3605-01-4
Formula : C16H18N4O2
M.W : 298.34
SMILES Code : C1(N2CCN(CC3=CC=C(OCO4)C4=C3)CC2)=NC=CC=N1
Synonyms :
Trivastal; Trivastan; EU 4200
MDL No. :MFCD00868264
InChI Key :OQDPVLVUJFGPGQ-UHFFFAOYSA-N
Pubchem ID :4850

Safety of Piribedil

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Piribedil

GPCR

Isoform Comparison

Biological Activity

Description
Piribedil is a potent and orally active agonist for dopamine D2 and dopamine D3 receptors. Additionally, it acts as an antagonist for α2-adrenoceptors. Piribedil exhibits inhibition of MLL1 methyltransferase activity with an EC50 of 0.18 μM. Its potential applications include research related to Parkinson's disease, circulatory disorders, and cancers [1][2][3][4].
Target
  • α-adrenergic receptor

    adrenoceptor α2A, pKi:7.1

    adrenoceptor α2C, pKi:7.2

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Noise-induced loss of Inner Hair Cell synaptic ribbons model Subcutaneous injection 10 mg/kg 3 days before and 3 days after, total 7 days To assess if Piribedil could reduce noise-induced loss of Inner Hair Cell synaptic ribbons. Results showed that Piribedil alone significantly reduced ribbon loss in the 5.5 mm region but did not reach significance in the 6.5 mm region. Sci Rep. 2016 Sep 30;6:30821

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00725478 Parkinson's Disease COMPLETED 2025-06-08 -
NCT00727727 Parkinson's Disease COMPLETED 2025-12-08 Medical Practice for Neurology... More >>, Dresden, 01307, Germany|Medical Practice for Neurology, Wedel, 22880, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.35mL

0.67mL

0.34mL

16.76mL

3.35mL

1.68mL

33.52mL

6.70mL

3.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories